TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
Shitalkumar P Zambad, Davinder Tuli, Anoop Mathur, Sameer A Ghalsasi, Anita R Chaudhary, Shailesh Deshpande, Ramesh C Gupta, Vijay Chauthaiwale, Chaitanya DuttTorrent Research Centre, Torrent Pharmaceuticals Ltd, Gujarat, IndiaBackground: Patients with diabesity have a significantly increa...
Guardado en:
Autores principales: | Zambad SP, Tuli D, Mathur A, Ghalsasi SA, Chaudhary AR, Deshpande S, Gupta RC, Chauthaiwale V, Dutt C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b3c46f8db6a4fa4898be37d7654f04c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Experimental diabesity research
Publicado: (2003) -
Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
por: Sachiho Miyata, et al.
Publicado: (2021) -
TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
por: Shitalkumar P Zambad, et al.
Publicado: (2011) -
Potential benefits of L. acidophilus in dyslipidemic rats
por: Onrapak Reamtong, et al.
Publicado: (2021) -
Experimental Study on the Permeation and Migration Rules of Pressurized Water in Textile-Reinforced Concrete (TRC)
por: Boxin Wang, et al.
Publicado: (2021)